HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MarcG who wrote ()	1/16/1998 4:28:00 PM
From: N. Dixon	Read Replies (1) of 857

Saw this message on the Yahoo board. Any comments? Subj: marshman By: hanoverbrett Date: Jan 13 1998 8:17 P.M PST Reply To: Msg. 65 by graham01 It would help if you did not speculate so much. HEB will be receiving approval for ampligen for CFS on Feb 2, 1998. Price fluctuation was based on dissemination to small investors. Next Tuesday's preliminary announcement of approval will be met with a projected rise to $ 7-9/ share, with price again projected at $14 -17/share after Feb 2 acknowledgement by FDA. Tell Goldshmidt he has terrible timing, You can thank me for this later. {BAC}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next